Boston Medical Sciences, Inc.
PrivateLast Round
Debt
Apr 28, 2026
Est. Valuation
$30.93M
Total Funding Raised
$18.07M
Company Overview
Boston Medical Sciences, Inc. operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Debt round in April 2026.
Boston Medical Sciences, Inc. is a healthtech company developing a non-invasive, AI-powered virtual colonoscopy system for colorectal cancer screening.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Medical Devices, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Boston Medical Sciences, Inc. Comparables
Compare Boston Medical Sciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AI Medical Service | 76% | |
| Dova Health Intelligence | 73% | |
| Magentiq Eye | 71% |
For institutional investors. Book with your work email.
Boston Medical Sciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 28, 2026 | ||||
| Series A | Feb 12, 2025 | ||||
| Seed | Oct 8, 2024 | ||||
| Seed | Oct 5, 2023 |
For institutional investors. Book with your work email.
Boston Medical Sciences, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Meiji Yasuda Life Insurance Company | Series A, Seed |
| Global Brain Corporation | Series A |
| JIC Venture Growth Investments | Series A |
| Beyond Next Ventures | Series A, Seed |
| Mitsubishi UFJ Capital | Series A |
| Community Healthcare Coordination Platform | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 12, 2025
$6.05M round led by JIC Venture Growth Investments.
- Oct 5, 2023
$3M round with Meiji Yasuda Life Insurance and Beyond Next Ventures.
For institutional investors. Book with your work email.
Boston Medical Sciences, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Boston Medical Sciences, Inc.'s valuation, stock price, and market status.
Is Boston Medical Sciences, Inc. a public or private company?
Boston Medical Sciences, Inc. is a private company.
What is the current stock price of Boston Medical Sciences, Inc.?
Boston Medical Sciences, Inc. is a private company, so its shares have no public market price. Caplight tracks Boston Medical Sciences, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Boston Medical Sciences, Inc. worth (valuation)?
Boston Medical Sciences, Inc.'s valuation is estimated at $30.9M based on funding round data.
Can I buy Boston Medical Sciences, Inc. stock?
Boston Medical Sciences, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Boston Medical Sciences, Inc.'s last funding round?
Boston Medical Sciences, Inc.'s most recent funding round was Debt on April 28, 2026.
Who are the main investors in Boston Medical Sciences, Inc.?
Key investors in Boston Medical Sciences, Inc. include JIC Venture Growth Investments.
Will Boston Medical Sciences, Inc. IPO soon?
No public IPO plans have been announced for Boston Medical Sciences, Inc..
How can I track Boston Medical Sciences, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Boston Medical Sciences, Inc.'s shares on secondary markets.